Jubin Joseph is a Cardiology physician affiliated with University of Southern California. OpenAlex indexes 46 publications with 1,135 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1510 San Pablo St
Los Angeles, CA 900335320
Telephone
323-865-1000Provider last certified this registry record 29 Mar 2023.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year2025107 payments$56,439openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202534 payments$31,016openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202543 payments$14,524openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.3%Calcium channel blocker20.6%Amlodipine Besylate84%Felodipine Er16%Part D<11 patientsBeta blocker17.8%Carvedilol36%Metoprolol Succinate36%Metoprolol Tartrate28%Part D<11 patients+ 7 more classes in this area
Blood & clotting
14.7%P2Y12 inhibitor11.3%Clopidogrel75%Brilinta25%Part D<11 patientsFactor Xa inhibitor3.4%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study
European Heart Journal
2023 - Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves
JACC: Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Andrew Moshfeghi, MD
University of Southern California
Kenneth Nies, MD
University of Southern California
Shuntaro Shinada, MD
University of Southern California
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”